Back
Harmony Biosciences Holdings Inc (HRMY)
PharmaceuticalsHRMY · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$39.36
−1.40%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$2.71
ROE
17.9%
Gross margin
76.5%
Debt/Equity
0.18x
Revenue growth
16.6%
Harmony Biosciences Holdings Inc — company intelligence
Earnings surprises
Q2 2026$1.28 vs $1.04 est+23.3%
Q1 2026$0.55 vs $0.71 est-22.3%
Q4 2025$0.38 vs $0.91 est-58.4%
Q3 2025$0.87 vs $0.86 est+1.6%
Analyst consensus · 17 analysts
12 Buy4 Hold1 Sell
Updated Oct 6, 2026
Recent SEC filings
4 — Insider transaction reportSep 18, 2026
4 — Insider transaction reportSep 9, 2026
10-Q — Quarterly reportAug 4, 2026
Latest news
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.